Skip to content

Irah King

photo of Dr. Irah King: research focus is on how immune cells communicate with their local environment to promote protective immune responses relevant to human disease., with a focus on immunity at barrier sites such as the gut, skin and lung

Position
Professor, Department of Microbiology and Immunology, Department of Medicine, McGill University
Canada Research Chair in Barrier Immunity
Director, McGill Centre for Microbiome Research

Research Interests

The focus of our research is to understand how immune cells communicate with their local environment to promote protective immune responses relevant to human disease. We are particularly interested in immunity at barrier sites such as the gut, skin and lung as these tissues face the complex task of maintaining homeostasis while directly interacting with the outside world.

Ongoing studies include:

  1. The molecular mechanisms of CD4+ T cell differentiation following intestinal helminth infection.
  2. The gut-lung axis in the context of infectious disease
  3. Innate immune mechanisms of disease tolerance during intestinal helminth infection.
  4. Regulation of skin-resident IL-17-producing T cells in the context of psoriatic-like inflammation.
  5. The impact of the microbiome on infection and inflammatory bowel diseases.

Check out this link to find out why parasites may be critical for human evolution!

This link describes how helminths can affect human fertility.

Featured Publications

A type 1 immune-stromal cell network mediates disease tolerance against intestinal infection.
Westfall S, Gentile ME, Olsen TM, Karo-Atar D, Bogza A, Röstel F, Pardy RD, Mandato G, Fontes G, Herbert D, Melichar HJ, Abadie V, Richer MJ, Vinh DC, Koenig JFE, Harrison OJ, Divangahi M, Weis S, Gregorieff A, King IL.
Cell. 2025 Jun 12;188(12):3135-3151.e22.
A type 1 immune-stromal cell network mediates disease tolerance against intestinal infection

Westfall S, Gentile ME, Olsen TM, Karo-Atar D, Bogza A, Röstel F, Pardy RD, Mandato G, Fontes G, Herbert D, Melichar HJ, Abadie V, Richer MJ, Vinh DC, Koenig JFE, Harrison OJ, Divangahi M, Weis S, Gregorieff A, King IL.
Cell. 2025 Jun 12;188(12):3135-3151.e22.

Bcl-6 expression by CD4+ T cells determines concomitant immunity and host resistance across distinct parasitic infections.
Meli AP, Russell GA, Swaminathan S, Weichselbaum L, MacMahon CA, Pernet E, Karo-Atar D, Rogers D, Rochette A, Fontes G, Mandl JN, Divangahi M, Klein OD, Gregorieff A, Stäger S, King IL.
Mucosal Immunol. 2023 Dec;16(6):801-816.
Bcl-6 expression by CD4+ T cells determines concomitant immunity and host resistance across distinct parasitic infections

Meli AP, Russell GA, Swaminathan S, Weichselbaum L, MacMahon CA, Pernet E, Karo-Atar D, Rogers D, Rochette A, Fontes G, Mandl JN, Divangahi M, Klein OD, Gregorieff A, Stäger S, King IL.
Mucosal Immunol. 2023 Dec;16(6):801-816.

Helminth-induced reprogramming of the stem cell compartment inhibits type 2 immunity. King. J Exp Med
Helminth-induced reprogramming of the stem cell compartment inhibits type 2 immunity

Karo-Atar D, Ouladan S, Javkar T, Joumier L, Matheson MK, Merritt S, Westfall S, Rochette A, Gentile ME, Fontes G, Fonseca GJ, Parisien M, Diatchenko L, von Moltke J, Malleshaiah M, Gregorieff A, King IL. J Exp Med. 2022 Sep 5;219(9):e20212311.

A type 1 immune-stromal cell network mediates disease tolerance against intestinal infection.
Westfall S, Gentile ME, Olsen TM, Karo-Atar D, Bogza A, Röstel F, Pardy RD, Mandato G, Fontes G, Herbert D, Melichar HJ, Abadie V, Richer MJ, Vinh DC, Koenig JFE, Harrison OJ, Divangahi M, Weis S, Gregorieff A, King IL.
Cell. 2025 Jun 12;188(12):3135-3151.e22.
Prostaglandin E2 amplifies IL-17 production by γδ T cells during barrier inflammation

Polese B, Thurairajah B, Zhang H, Soo CL, McMahon CA, Fontes G, Hussain SNA, Abadie V, King ILCell Rep. 2021 Jul 27;36(4):109456.

Bcl-6 expression by CD4+ T cells determines concomitant immunity and host resistance across distinct parasitic infections.
Meli AP, Russell GA, Swaminathan S, Weichselbaum L, MacMahon CA, Pernet E, Karo-Atar D, Rogers D, Rochette A, Fontes G, Mandl JN, Divangahi M, Klein OD, Gregorieff A, Stäger S, King IL.
Mucosal Immunol. 2023 Dec;16(6):801-816.
Training the metaorganism: the microbial counterpart

King IL, Divangahi M. Cell. 2021 Jan;184(3):574-576.

Helminth-induced reprogramming of the stem cell compartment inhibits type 2 immunity. King. J Exp Med
NK cell recruitment limits tissue damage during an enteric helminth infection

Gentile ME, Li Y, Robertson A, Shah K, Fontes G, Kaufmann E, Polese B, Khan N, Parisien M, Munter HM, Mandl JN, Diatchenko L, Divangahi M, King ILMucosal Immunol. 2020 Mar;13(2):357-370.

A type 1 immune-stromal cell network mediates disease tolerance against intestinal infection.
Westfall S, Gentile ME, Olsen TM, Karo-Atar D, Bogza A, Röstel F, Pardy RD, Mandato G, Fontes G, Herbert D, Melichar HJ, Abadie V, Richer MJ, Vinh DC, Koenig JFE, Harrison OJ, Divangahi M, Weis S, Gregorieff A, King IL.
Cell. 2025 Jun 12;188(12):3135-3151.e22.
CD109 Restrains Activation of Cutaneous IL-17-Producing γδ T Cells by Commensal Microbiota

Zhang H, Carnevale G, Polese B, Simard M, Thurairajah B, Khan N, Gentile ME, Fontes G, Vinh DC, Pouliot R and King ILCell Reports. 2019 Oct 8;29(2):391-405.

Bcl-6 expression by CD4+ T cells determines concomitant immunity and host resistance across distinct parasitic infections.
Meli AP, Russell GA, Swaminathan S, Weichselbaum L, MacMahon CA, Pernet E, Karo-Atar D, Rogers D, Rochette A, Fontes G, Mandl JN, Divangahi M, Klein OD, Gregorieff A, Stäger S, King IL.
Mucosal Immunol. 2023 Dec;16(6):801-816.
Intestinal dysbiosis compromises alveolar macrophage immunity to Mycobacterium tuberculosis

Khan N, Mendonca L, Dhariwal A, Fontes G, Menzies D, Xia J, Divangahi M, King ILMucosal Immunol. 2019 May;12(3):772-783.

Helminth-induced reprogramming of the stem cell compartment inhibits type 2 immunity. King. J Exp Med
T follicular helper cell-derived IL-4 is required for IgE production during intestinal helminth infection

Meli AP, Fontes G, Leung Soo C, King ILJ Immunol. 2017 Jul 1;199(1):244-252.

A type 1 immune-stromal cell network mediates disease tolerance against intestinal infection.
Westfall S, Gentile ME, Olsen TM, Karo-Atar D, Bogza A, Röstel F, Pardy RD, Mandato G, Fontes G, Herbert D, Melichar HJ, Abadie V, Richer MJ, Vinh DC, Koenig JFE, Harrison OJ, Divangahi M, Weis S, Gregorieff A, King IL.
Cell. 2025 Jun 12;188(12):3135-3151.e22.
The integrin LFA-1 Controls T follicular Helper Cell Generation and Maintenance

Meli AP, Fontés G, Avery DT, Leddon SA, Tam M, Elliot M, Ballesteros-Tato A, Miller J, Stevenson MM, Fowell DJ, Tangye SG, King ILImmunity. 2016 Oct 18;45(4):831-846.

In the News

MI4-Pathy Seed Fund Grant Winners

Congrats to Irah King and Dao Nguyen who received MI4-Pathy Seed Funding in support of their innovative research in infection and antimicrobial resistance.

Spring 2025 Student Awards

Congratulations to the 2025 recipients of FRQS and CIHR studentship and fellowship awards! We wish you much success!

Spring 2023 Student Awards

Congratulations to the 2023 recipients of FRQS and CIHR studentship and fellowship awards! We wish you much success!


Contact Information

Meakins-Christie Laboratories
RI-MUHC, Block E
Office EM2.2232
Lab E03.4380
1001 Decarie Blvd.
Montreal QC H4A 3J1
Canada

Tel: 514-934-1934
E-Mail: irah.king [at] mcgill.ca

Education & Training

BA (Psychology), Ohio University, 2000
MSc (Physical Therapy), U Pittsburgh, 2002
PhD (Immunology), U Rochester, 2008
PDF Trudeau Institute, 2012